Who Buys Esomeprazole from India — 1634 Importers Behind a $456.5M Market
India's esomeprazole import market is served by 1634 active buyers who collectively imported $456.5M across 9,532 shipments. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with a 14.2% market share, followed by SUN PHARMA CANADA INC. and CIPLA USA INC UPS SUPPLY CHAIN SOLU. The top 5 buyers together control 47.6% of total import value, reflecting a moderately competitive buyer landscape.
Top Esomeprazole Importers — Ranked by Import Value
YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the leading esomeprazole importer from India, holding a 14.2% share of the $456.5M market across 9,532 shipments from 1634 buyers. The top 5 buyers — YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), SUN PHARMA CANADA INC. (CANADA), CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), DELTA IMPORT-EXPORT MEDICAL CO LTD (VIETNAM), MYLAN PHARMACEUTICALS ULC, (CANADA) — collectively control 47.6% of total import value.
Top Esomeprazole Buyers & Importers
Ranked by import value · 1634 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANT | $64.9M | 5 | 14.2% |
| 2 | SUN PHARMA CANADA INC.CANADA ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]HELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMY | $54.6M | 5 | 12.0% |
| 3 | CIPLA USA INC UPS SUPPLY CHAIN SOLUUNITED STATES ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEAHELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMY | $47.3M | 5 | 10.4% |
| 4 | DELTA IMPORT-EXPORT MEDICAL CO LTDVIETNAM SOMEXWELL-40TROXIPE (KIT OF ESOMEPRAZOLE MAGNESIUM DYESOM 40MG - ESOMEPRAZOLE 40 MG CAPS(BAT | $25.5M | 5 | 5.6% |
| 5 | MYLAN PHARMACEUTICALS ULC,CANADA ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | $24.8M | 5 | 5.4% |
| 6 | M/S. SUN PHARMA ANZ PTY LTDAUSTRALIA SOMEXWELL-40ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS] | $16.5M | 5 | 3.6% |
| 7 | CIPLA USA INC UPS SUPPLY CHAIN SOLUNITED STATES ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEAHELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMY | $10.0M | 5 | 2.2% |
| 8 | YUSEN LOGISTICS BENELUXBELGIUM ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANT | $9.4M | 5 | 2.1% |
| 9 | SUN PHARMA ANZ PTY LTD.AUSTRALIA ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]HELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMY | $7.9M | 5 | 1.7% |
| 10 | BIOCON PHARMA INCUNITED STATES ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | $7.6M | 5 | 1.7% |
| 11 | DR REDDYS LABORATORIES INCUNITED STATES SOMEXWELL-40ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEAESOMEPRAZOLE TABLETS 40MG (ESOMEPRAZOL R | $6.3M | 5 | 1.4% |
| 12 | EUROFARMA LABORAT?RIOS S/ABRAZIL | $5.0M | 5 | 1.1% |
| 13 | DR. REDDYS LABORATORIES, INCUNITED STATES SOMEXWELL-40ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEAESOMEPRAZOLE TABLETS 40MG (ESOMEPRAZOL R | $4.7M | 5 | 1.0% |
| 14 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | $4.3M | 5 | 0.9% |
| 15 | CIPLA KENYA LTD C/O IMPERIAL MANAGEKENYA ESCLAM KIT[PS:7X1X6X10100PAC=424200 NOS]ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEAHELI-CURE ESOMEPRAZOLE 40MG/ CLARITHROMY | $4.0M | 5 | 0.9% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Esomeprazole — and from which countries?
Flow of Esomeprazole exports from India: each country's share and the named importers behind the numbers
Esomeprazole — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $111.5M through 494 shipments. This represents a market share of 24.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $47.3M (42.4% of country's total business)
• CIPLA USA INC UPS SUPPLY CHAIN SOL - $10.0M (9.0% of country's total business)
• BIOCON PHARMA INC - $7.6M (6.8% of country's total business)
• DR REDDYS LABORATORIES INC - $6.3M (5.7% of country's total business)
• DR. REDDYS LABORATORIES, INC - $4.7M (4.2% of country's total business)
• Rest of United States's importers - $35.6M (31.9% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $225.7K, indicating premium pricing strategy compared to the market average of $47.9K.
United States is a key market for Esomeprazole imports, representing 24.4% of total trade value.
2Canada
Canada emerges as the second largest importing country, achieving a total trade value of $89.6M through 98 shipments. This represents a market share of 19.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• SUN PHARMA CANADA INC. - $54.6M (61.0% of country's total business)
• MYLAN PHARMACEUTICALS ULC, - $24.8M (27.6% of country's total business)
• SUN PHARMA CANADA INC - $3.8M (4.2% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $914.3K, indicating premium pricing strategy compared to the market average of $47.9K.
Canada is a key market for Esomeprazole imports, representing 19.6% of total trade value.
3Belgium
Belgium emerges as the third largest importing country, achieving a total trade value of $74.8M through 718 shipments. This represents a market share of 16.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $64.9M (86.9% of country's total business)
• YUSEN LOGISTICS BENELUX - $9.4M (12.5% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $104.1K, indicating premium pricing strategy compared to the market average of $47.9K.
Belgium is a key market for Esomeprazole imports, representing 16.4% of total trade value.
4Vietnam
Vietnam emerges as the fourth largest importing country, achieving a total trade value of $29.6M through 7 shipments. This represents a market share of 6.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Vietnam has a diverse importer base, with their top importers including:
• DELTA IMPORT-EXPORT MEDICAL CO LTD - $25.5M (86.0% of country's total business)
Key Insight: Vietnam demonstrates strong market positioning with an average shipment value of $4.2M, indicating premium pricing strategy compared to the market average of $47.9K.
Vietnam is a key market for Esomeprazole imports, representing 6.5% of total trade value.
5Australia
Australia emerges as the fifth largest importing country, achieving a total trade value of $29.5M through 341 shipments. This represents a market share of 6.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• M/S. SUN PHARMA ANZ PTY LTD - $16.5M (56.1% of country's total business)
• SUN PHARMA ANZ PTY LTD. - $7.9M (26.7% of country's total business)
• SUN PHARMA ANZ PTY LTD - $3.0M (10.1% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $86.5K, indicating premium pricing strategy compared to the market average of $47.9K.
Australia is a key market for Esomeprazole imports, representing 6.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Esomeprazole buyer market intelligence
1Buyer Segment Analysis
The 1,634 buyers of Esomeprazole from India can be categorized into several segments:
1. Distributors: Entities that purchase Esomeprazole in bulk to supply to various healthcare providers. Examples include YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $64.93M) and YUSEN LOGISTICS BENELUX (Belgium, $9.38M). These distributors typically place large, regular orders to maintain a steady supply chain for their clients.
2. Pharmaceutical Companies: Companies that import Esomeprazole for formulation, packaging, and distribution under their brand names. Notable buyers are SUN PHARMA CANADA INC. (Canada, $54.64M), CIPLA USA INC UPS SUPPLY CHAIN SOLU (United States, $47.28M), and BIOCON PHARMA INC (United States, $7.60M). Their purchasing patterns are aligned with production schedules and market demand forecasts.
3. Contract Manufacturers: Firms that import Esomeprazole to manufacture products on behalf of other companies. M/S. SUN PHARMA ANZ PTY LTD (Australia, $16.54M) and SUN PHARMA ANZ PTY LTD. (Australia, $7.87M) fall into this category. Their orders are project-based and can vary in volume depending on contractual agreements.
4. Re-exporters: Companies that import Esomeprazole with the intent to export it to other markets. DELTA IMPORT-EXPORT MEDICAL CO LTD (Vietnam, $25.49M) exemplifies this segment. Their purchasing behavior is influenced by international demand and trade agreements.
Understanding these segments helps in tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Esomeprazole buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Esomeprazole are as follows:
1. United States:
2. Canada:
3. Belgium:
4. Vietnam:
5. Australia:
Compliance with these regulations is crucial for market entry and sustained operations in these countries.
Demand Drivers & Market Opportunity
TransData Nexus Esomeprazole buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Esomeprazole in importing countries is driven by several factors:
1. Disease Prevalence: Esomeprazole is primarily used to treat gastroesophageal reflux disease (GERD) and other acid-related disorders. The increasing prevalence of these conditions, linked to lifestyle changes and dietary habits, has led to a higher demand for effective treatments.
2. Government Healthcare Programs: Many countries have implemented healthcare programs that subsidize or cover the cost of essential medicines, including Esomeprazole. For instance, Canada's public healthcare system provides coverage for prescription drugs, enhancing accessibility for patients.
3. Universal Health Coverage Expansion: The global push towards universal health coverage has led to increased procurement of essential medicines. Countries expanding their healthcare coverage are investing in a broader range of pharmaceuticals to meet the needs of their populations.
4. WHO Essential Medicines List Procurement: Esomeprazole's inclusion in the WHO Model List of Essential Medicines underscores its importance in treating priority health conditions. This inclusion encourages countries to prioritize its procurement to ensure availability.
5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender processes to ensure cost-effectiveness and supply security. This system often leads to bulk purchasing agreements, benefiting suppliers with competitive pricing and consistent quality.
With 1,634 buyers across 147 countries, the market for Esomeprazole presents significant opportunities for suppliers who can navigate regulatory landscapes and meet the diverse needs of these markets.
Common Questions — Esomeprazole Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest esomeprazole buyer importing from India?
Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $64.9M in imports and a 14.2% market share — the highest of any single esomeprazole importer. SUN PHARMA CANADA INC. (CANADA) and CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) are the next largest buyers.
QHow many companies buy esomeprazole from India?
There are 1634 active esomeprazole buyers importing from India, with a combined market of $456.5M across 9,532 shipments to 147 countries. The top 5 buyers hold 47.6% of total import value, while the remaining 1629 buyers handle the other 52.4%.
QWhich countries import the most esomeprazole from India?
The top importing countries for esomeprazole from India are United States (24.4%), Canada (19.6%), Belgium (16.4%), Vietnam (6.5%), Australia (6.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of esomeprazole, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for esomeprazole from India?
The average import transaction value for esomeprazole from India is $47.9K, with an average unit price of $4.31 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Esomeprazole buyer market intelligence
1Buyer Segment Analysis
The 1,634 buyers of Esomeprazole from India can be categorized into several segments:
1. Distributors: Entities that purchase Esomeprazole in bulk to supply to various healthcare providers. Examples include YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $64.93M) and YUSEN LOGISTICS BENELUX (Belgium, $9.38M). These distributors typically place large, regular orders to maintain a steady supply chain for their clients.
2. Pharmaceutical Companies: Companies that import Esomeprazole for formulation, packaging, and distribution under their brand names. Notable buyers are SUN PHARMA CANADA INC. (Canada, $54.64M), CIPLA USA INC UPS SUPPLY CHAIN SOLU (United States, $47.28M), and BIOCON PHARMA INC (United States, $7.60M). Their purchasing patterns are aligned with production schedules and market demand forecasts.
3. Contract Manufacturers: Firms that import Esomeprazole to manufacture products on behalf of other companies. M/S. SUN PHARMA ANZ PTY LTD (Australia, $16.54M) and SUN PHARMA ANZ PTY LTD. (Australia, $7.87M) fall into this category. Their orders are project-based and can vary in volume depending on contractual agreements.
4. Re-exporters: Companies that import Esomeprazole with the intent to export it to other markets. DELTA IMPORT-EXPORT MEDICAL CO LTD (Vietnam, $25.49M) exemplifies this segment. Their purchasing behavior is influenced by international demand and trade agreements.
Understanding these segments helps in tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Esomeprazole buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Esomeprazole are as follows:
1. United States:
2. Canada:
3. Belgium:
4. Vietnam:
5. Australia:
Compliance with these regulations is crucial for market entry and sustained operations in these countries.
Demand Drivers & Market Opportunity
TransData Nexus Esomeprazole buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Esomeprazole in importing countries is driven by several factors:
1. Disease Prevalence: Esomeprazole is primarily used to treat gastroesophageal reflux disease (GERD) and other acid-related disorders. The increasing prevalence of these conditions, linked to lifestyle changes and dietary habits, has led to a higher demand for effective treatments.
2. Government Healthcare Programs: Many countries have implemented healthcare programs that subsidize or cover the cost of essential medicines, including Esomeprazole. For instance, Canada's public healthcare system provides coverage for prescription drugs, enhancing accessibility for patients.
3. Universal Health Coverage Expansion: The global push towards universal health coverage has led to increased procurement of essential medicines. Countries expanding their healthcare coverage are investing in a broader range of pharmaceuticals to meet the needs of their populations.
4. WHO Essential Medicines List Procurement: Esomeprazole's inclusion in the WHO Model List of Essential Medicines underscores its importance in treating priority health conditions. This inclusion encourages countries to prioritize its procurement to ensure availability.
5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender processes to ensure cost-effectiveness and supply security. This system often leads to bulk purchasing agreements, benefiting suppliers with competitive pricing and consistent quality.
With 1,634 buyers across 147 countries, the market for Esomeprazole presents significant opportunities for suppliers who can navigate regulatory landscapes and meet the diverse needs of these markets.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 1634 global importers of Esomeprazole identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 9,532 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 147 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9,532 Verified Shipments
1634 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists